Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 16 clients • 20 examiners • 17 art units • 0 of 20 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pearl Cohen Zedek Latzer Baratz LLP has a portfolio of 10107 career applications, primarily in Biotechnology & Pharmaceuticals. The firm's resolved allowance rate is 79.59 percent. Prosecution involves an average of 3.62 office actions per allowance. There are 26 pending office actions currently active.
This workload is part of the firm's experience with 10107 career applications. The 79.59 percent resolved allowance rate is a performance indicator for the firm in Biotechnology & Pharmaceuticals. The 3.62 average office actions per allowance reflects the firm's engagement with the patent office. This firm's data shows a scale of operation, with 10107 career applications and a success rate. The 79.59 percent resolved allowance rate provides a baseline for performance. With 26 pending office actions, the firm is managing an active docket in the Biotechnology & Pharmaceuticals sector, demonstrating its capacity for prosecution. The 3.62 average office actions per allowance is a consistent metric across its 10107 career applications.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (20%) |
| §103 only | 5 (25%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 9 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MANOHARAN, MUTHUSWAMY GANAPATHY | 1 | 65.2% | +16.0% |
| SKROBARCZYK III, ROBERT ANTHONY | 1 | 16.7% | +16.3% |
| BADER, ROBERT N. | 1 | 44.6% | +26.0% |
| BAYS, PAMELA M | 1 | 71.7% | +37.5% |
| ABUZEINEH, HANAN ISAM | 1 | 53.2% | +54.3% |
| NGUYEN, PHU K | 1 | 85.9% | +7.9% |
| EMCH, GREGORY S | 1 | 48.5% | +43.6% |
| LEE, WILLIAM Y | 1 | 47.9% | +34.1% |
| TRAN, VINCENT HUY | 1 | 86.6% | +9.7% |
| LEY, SALLY THI | 1 | 22.7% | +14.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18396854 | SYSTEM AND METHOD FOR TRAINING AND USING AN IMPLICIT REPRESENTATION NETWORK FOR REPRESENTING THREE DIMENSIONAL OBJECTS | NGUYEN, PHU K | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | IVICH, FERNANDO NMN | 168d overdue |
| 17928767 | INHIBITION OF BMI1 ELIMINATES CANCER STEM CELLS AND ACTIVATES ANTITUMOR IMMUNITY | LU, CHENG | 26d overdue |
| 17628112 | MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL INSTILLATION, PREPARATION AND USE THEREOF | SABILA, MERCY HELLEN | 14d |
| 18657914 | SYSTEM AND METHOD OF PROGRESSION ASSESSMENT OF A NEUROLOGICAL DISEASE | SKROBARCZYK III, ROBERT ANTHONY | 40d |
| 18383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | LEE, WILLIAM Y | 48d |
| 18136072 | QUANTIFYING THE RESPONSE-SPECIFICITY OF MONONUCLEAR CELLS AND USES THEREOF | SCHULTZHAUS, JANNA NICOLE | 63d |
| 17642515 | IMMUNOACTIVE MICROPARTICLES AND USES THEREOF | MIDDLETON, DANAYA L | 70d |
| 18840498 | METHOD TO MANAGE NATIONAL ROAMING IN DISASTER SITUATION | MANOHARAN, MUTHUSWAMY GANAPATHY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | EMCH, GREGORY S | 31d overdue |
| 18583763 | IMPLANTABLE LEADLESS PACEMAKERS | BAYS, PAMELA M | 22d overdue |
| 18657914 | SYSTEM AND METHOD OF PROGRESSION ASSESSMENT OF A NEUROLOGICAL DISEASE | SKROBARCZYK III, ROBERT ANTHONY | 40d |
| 18383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | LEE, WILLIAM Y | 48d |
| 18840498 | METHOD TO MANAGE NATIONAL ROAMING IN DISASTER SITUATION | MANOHARAN, MUTHUSWAMY GANAPATHY | — |
| 18591919 | GRAPHICS TEXTURE PROCESSING | BADER, ROBERT N. | — |
| 18576102 | METHODS OF GENERATING MESENCHYAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS IN A BIOREACTOR SYSTEM | ABUZEINEH, HANAN ISAM | — |
| 18273255 | METHOD OF AND SYSTEM FOR PROVIDING AN AGGREGATED MACHINE LEARNING MODEL IN A FEDERATED LEARNING ENVIRONMENT AND DETERMINING RELATIVE CONTRIBUTION OF LOCAL DATASETS THERETO | LEY, SALLY THI | — |
| Art Unit | Apps |
|---|---|
| 1678 | 2 |
| 1615 | 2 |
| 3792 | 1 |
| 2611 | 1 |
| 3796 | 1 |
| 1633 | 1 |
| 2616 | 1 |
| 1623 | 1 |
| 2115 | 1 |
| 2147 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18840498 | METHOD TO MANAGE NATIONAL ROAMING IN DISASTER SITUATION | Telit Cinterion Deutschland GmbH | MANOHARAN, MUTHUSWAMY GANAPATHY | §103§112 | Non-Final OA | — | Pending | Aug 22, 2024 | |
| 18657914 | SYSTEM AND METHOD OF PROGRESSION ASSESSMENT OF A NEUROLOGICAL DISEASE | Owlytics Healthcare Ltd. | SKROBARCZYK III, ROBERT ANTHONY | 3792 | §101§102§103 | Non-Final OA | 40d | Pending | May 08, 2024 |
| 18591919 | GRAPHICS TEXTURE PROCESSING | Arm Limited | BADER, ROBERT N. | 2611 | §103§112 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18583763 | IMPLANTABLE LEADLESS PACEMAKERS | Pacesetter, Inc. | BAYS, PAMELA M | 3796 | §103Other | Non-Final OA | 22d overdue | Pending | Feb 21, 2024 |
| 18576102 | METHODS OF GENERATING MESENCHYAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS IN A BIOREACTOR SYSTEM | BRAINSTORM CELL THERAPEUTICS LTD. | ABUZEINEH, HANAN ISAM | 1633 | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2024 |
| 18396854 | SYSTEM AND METHOD FOR TRAINING AND USING AN IMPLICIT REPRESENTATION NETWORK FOR REPRESENTING THREE DIMENSIONAL OBJECTS | De-Identification Ltd. | NGUYEN, PHU K | 2616 | §103 | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18542382 | METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS | The Trustees of the University of Pennsylvania | EMCH, GREGORY S | 1678 | §112Other | Non-Final OA | 31d overdue | Pending | Dec 15, 2023 |
| 18383256 | AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES | The Regents of the University of California | LEE, WILLIAM Y | 1623 | §102§103§112 | Non-Final OA | 48d | Pending | Oct 24, 2023 |
| 18450641 | APPARATUS AND METHOD FOR IDENTIFYING CRITICAL FEATURES USING MACHINE LEARNING | Markforged, Inc. | TRAN, VINCENT HUY | 2115 | §101§102§103 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18273255 | METHOD OF AND SYSTEM FOR PROVIDING AN AGGREGATED MACHINE LEARNING MODEL IN A FEDERATED LEARNING ENVIRONMENT AND DETERMINING RELATIVE CONTRIBUTION OF LOCAL DATASETS THERETO | Concordia University Inc. | LEY, SALLY THI | 2147 | §103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18254851 | PRECISE LABELING OF PROTEIN SCAFFOLDS WITH CARGO FOR USE IN BIOMEDICAL APPLICATIONS | Alphathera LLC | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | — | Pending | May 27, 2023 |
| 18136072 | QUANTIFYING THE RESPONSE-SPECIFICITY OF MONONUCLEAR CELLS AND USES THEREOF | The Regents of the University of California | SCHULTZHAUS, JANNA NICOLE | 1685 | §101§103§112 | Non-Final OA | 63d | Pending | Apr 18, 2023 |
| 18128328 | STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF | Mayne Pharma LLC | TCHERKASSKAYA, OLGA V | 1615 | §103§112DP | Final Rejection | — | Pending | Mar 30, 2023 |
| 18013508 | GSK3 INHIBITOR-LOADED NANO FORMULATIONS AS A CANCER IMMUNOTHERAPEUTIC | The Regents of the University of California | KAMM, JUDITH MARIE | 1611 | §103Other | Final Rejection | 41d | Pending | Dec 28, 2022 |
| 17928767 | INHIBITION OF BMI1 ELIMINATES CANCER STEM CELLS AND ACTIVATES ANTITUMOR IMMUNITY | The Regents of the University of California | LU, CHENG | 1642 | §102§103§112 | Non-Final OA | 26d overdue | Pending | Nov 30, 2022 |
| 17915625 | A LYOPHILIZED TEST KIT FOR DETERMINATION OF ANTIMICROBIAL BIOLOGICAL ACTIVITY OF PHAGE PREPARATIONS AGAINST THE BACTERIA STAPHYLOCOCCUS AUREUS | Mb Pharma S.R.O. | SIFFORD, JEFFREY MARK | 1671 | §101§112 | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17642515 | IMMUNOACTIVE MICROPARTICLES AND USES THEREOF | The Regents of the University of California | MIDDLETON, DANAYA L | 1674 | §102§112 | Final Rejection | 70d | Pending | Mar 11, 2022 |
| 17640920 | GRAFT PATCH FOR THE TREATMENT OF MYOPIA AND OPHTHALMIC CONDITIONS | Corneat Vision Ltd. | TRUONG, QUANGLONG N | 1615 | §103§112 | Non-Final OA | — | Pending | Mar 07, 2022 |
| 17628112 | MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL INSTILLATION, PREPARATION AND USE THEREOF | Peter Birinyi | SABILA, MERCY HELLEN | 1654 | §103§112 | Final Rejection | 14d | Pending | Jan 18, 2022 |
| 17614563 | ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | Yeda Research And Development Co. Ltd. | IVICH, FERNANDO NMN | 1678 | §103§112Other | Final Rejection | 168d overdue | Pending | Nov 29, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial